Your prescription drugs shouldn’t cost more than your mortgage. Inside the broken math that got us here.
We will never make medicine affordable if how to tie a drug’s price to its value is solely determined by the companies creating the drugs.
Similar Posts
Beyond automation: The AI productivity j-curve
‘Is my generation doomed?’ That’s what one Stanford graduating senior asked Professor Erik Brynjolfsson, economist and director of the Stanford Digital Economy Lab. The professor had seen the data, so he didn’t dismiss the question. But as productivity gains begin to emerge, Brynjolfsson argues that the biggest opportunity lies not in replacing workers but in…
Njord Partners’ Arvid Trolle: AI a ‘key part’ of operational improvements
Arvid Trolle, Njord Partners Njord Partners is leaning into artificial intelligence to improve operations at its portfolio companies, including applying the technology in supply chains to improve demand forecasting and inventory management, Arvid Trolle, co-founder and partner, told PE Hub. London-headquartered Njord invests in European mid-market companies with enterprise values of €40 million-€500 million and…
The cholesterol shot you couldn’t afford is now a pill
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs. The drug from Merck was OK’d on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard medications for cutting heart attack risk. Merck will market…
Why Apple’s AI Strategy Looks Different From Everyone Else’s
Apple (AAPL -7.35%) might as well be taken out of the Magnificent Seven group of businesses. The company doesn’t seem to be going all in on artificial intelligence (AI) as its peers are. Of these seven companies, Nvidia sells the chips at the center of the boom. Tesla is now generating negative free cash flow…
Twilio Raised Its Full-Year Growth Guide to 18% and Posted Record Revenue of $1.5 Billion. The Stock Rose 25% in a Day.
Twilio (TWLO +24.89%) raised its 2026 outlook on Aug. 6. It now expects revenue to grow 18% to 18.5% this year, up from the 14% to 15% it guided just three months ago. The raise came alongside $1.50 billion of second-quarter revenue, up 22% year over year and the highest quarterly total in Twilio’s history…
WealthStack Roundup: Wells Fargo Launches AI Teammate Tool
Wells Fargo has launched AI Teammate, an artificial intelligence-powered capability embedded within the firm’s Advisor Gateway (launched in May) that is meant to help advisors, client associates and support teams access information and complete everyday work and administrative tasks. The tool will be available to financial advisors across all Wealth & Investment Management advisor channels,…
